✦ LIBER ✦

13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION

✍ Scribed by Everson, G.T.; Di Bisceglie, A.M.; Vierling, J.M.; Hsieh, F.; Trenkle, J.D.; Kanwar, B.; Subramanian, M.; McHutchison, J.G.; Ghalib, R.H.; Rustgi, V.K.; Kwo, P.Y.

Book ID: 123053194
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 64 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60015-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

865 12 WEEK RESPONSE-GUIDED TREATMENT WI

865 12 WEEK RESPONSE-GUIDED TREATMENT WITH THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, PLUS PEGYLATED INTERFERON/RIBAVIRIN IN TREATMENT NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS

✍ Marcellin, P.; Manns, M.P.; Janczewska, E.; Muir, A.J.; Wu, X.; Trenkle, J.D.; K 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

68 ANTIVIRAL EFFICACY OF THE NS3 PROTEAS

68 ANTIVIRAL EFFICACY OF THE NS3 PROTEASE INHIBITOR, GS-9451, NON-NUCLEOSIDE NS5b INHIBITOR, TEGOBUVIR, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS

✍ Pol, S.; Jablkowski, M.; Trenkle, J.D.; Kanwar, B.; Bekele, B.N.; Subramanian, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Dynamics of resistance mutations to NS3

Dynamics of resistance mutations to NS3 protease inhibitors in a cohort of Brazilian patients chronically infected with hepatitis C virus (genotype 1) treated with pegylated interferon and ribavirin: a prospective longitudinal study

✍ Luísa Hoffmann, Juliene Antonio Ramos, Elizabeth Valentin de Souza… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 164 KB

Su1067 Drug Resistance Mutations in the

Su1067 Drug Resistance Mutations in the Ns3 and NS5A Regions in Patients With Hepatitis C Virus Genotype 1b and Response to Telaprevir Plus Pegylated-Interferon-Alpha 2B and Ribavirin Combination Therapy

✍ Hayashi, Kazuhiko; Ishigami, Masatoshi; Ishizu, Yoji; Kuzuya, Teiji; Honda, Taka 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Efficacy of boceprevir, an NS3 protease

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

✍ Paul Y Kwo; Eric J Lawitz; Jonathan McCone; Eugene R Schiff; John M Vierling; Da 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 378 KB

T1986 The Prevalence of Hepatitis C Viru

T1986 The Prevalence of Hepatitis C Virus Genotype 1A in Japan and Correlation Between the Mutations in the NS5A Region With Response to Pegylated-Interferon-Alpha 2B Plus Ribavirin Combination Therapy

✍ Hayashi, Kazuhiko; Katano, Yoshiaki; Ishigami, Masatoshi; Nakano, Isao; Itoh, Ak 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 96 KB